Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Outcome of Multiple Myeloma Associated With Autoimmune Hemolytic Anemia [NA]
This clinical trial update reports the outcomes for patients with multiple myeloma associated with autoimmune hemolytic anemia.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Removing Transfusion Dependence as a Barrier to Hospice Enrollment [NA]
A completed clinical trial update indicates that transfusion dependence was removed as a barrier to hospice enrollment for patients with hem…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial of PHE885 CAR-T Therapy for adults with relapsed and refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Isa-VRD in TIE HRMM [Phase 4]
Phase 4 trial update for Isa-VRD in multiple myeloma; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma [Phase 2]
Phase 2 trial evaluating upfront CAR-T cell therapy to upgrade response in multiple myeloma; results have been posted for this completed stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager [Phase 4]
Phase 4 clinical trial update describing the use of immunoglobulin therapy in multiple myeloma patients treated with a BCMA-directed T cell …
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Non-invasive MRD Assessment in Multiple Myeloma
This document provides an update on a completed clinical trial evaluating a non-invasive method for assessing minimal residual disease in mu…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma [Phase 1]
Phase 1 study of ibrutinib in combination with lenalidomide and dexamethasone for relapsed/refractory multiple myeloma has completed with re…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
A Phase 3 trial evaluating VMP with high-dose melphalan followed by VRD consolidation and lenalidomide maintenance in newly diagnosed multip…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy [Phase 3]
Phase 3 clinical trial comparing allogeneic stem cell transplantation versus conventional salvage therapy for relapsed or progressive multip…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Impact of Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma [NA]
This clinical trial update evaluates the impact of paramedical consultations on oncological supportive care for outpatients with multiple my…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: A Study of WVT078 in Patients With Multiple Myeloma (MM) [Phase 1]
A Phase 1 study of WVT078 in patients with multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults [Phase 4]
This Phase 4 trial assessed the humoral immune response to the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in immunocompromised adults compa…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM [Phase 2]
A Phase 2 trial update evaluating a quadruplet combination of isatuximab, lenalidomide, bortezomib, and dexamethasone for newly diagnosed mu…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
This Phase 1/2 trial evaluates the safety and activity of a carfilzomib, pomalidomide, and dexamethasone combination in adults with relapsed…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning [Phase 2]
Phase 2 trial in multiple myeloma patients aged 65 or younger who have at least 50% response after autologous transplant is evaluating an al…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluated stem cell transplantation with or without the growth factor tbo-filgrastim in patients with multiple myeloma or non-…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial of LCAR-B38M BCMA-directed CAR-T cells in Chinese participants with relapsed or refractory multiple myeloma has been termina…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma. [Phase 2]
Phase II randomized trial evaluating cyclophosphamide and dexamethasone with ixazomib in relapsed or refractory multiple myeloma has complet…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Health Through Activity: A Pilot Study of a Rehabilitation Intervention for People Living With Multiple Myeloma [NA]
ClinicalTrials.gov reports the completion of a pilot rehabilitation intervention study for people living with multiple myeloma, with results…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse [NA]
A terminated Phase 1-2 study evaluating total bone marrow irradiation with helicoidal tomotherapy for first relapse multiple myeloma has res…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: FT576 in Subjects With Multiple Myeloma [Phase 1]
This document is a status update for a Phase 1 clinical trial of FT576 in multiple myeloma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma [Phase 3]
Phase 3 trial evaluating isatuximab in combination with lenalidomide and dexamethasone for high-risk smoldering multiple myeloma; currently …
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 clinical trial is evaluating daratumumab after stem cell transplant in patients with multiple myeloma. The study is currently acti…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy [Phase 1]
A Phase 1 trial evaluating the combination of duvelisib with BMS-986345 in lymphoid malignancies, including non-Hodgkin lymphoma and Hodgkin…